Potassium assay in potassium citrate and citric acid oral solution

Significance of the Topic

Potassium citrate and citric acid oral solutions are critical systemic alkalizers for maintaining urinary pH and avoiding sodium overload in sensitive patients. Accurate potassium quantification ensures patient safety and product compliance with pharmacopeial quality standards.

Objectives and Study Overview

This study aims to validate an ion chromatography (IC) assay for potassium determination in potassium citrate and citric acid oral solutions following the U.S. Pharmacopeia (USP) monograph requirements. The work addresses the replacement of titration-based identification with a chromatographic approach for accelerated and reliable quality control.

Methodology and Validation

Sample preparation involves dilution of commercial oral solutions to obtain working standards (3.0–22.5 µg/mL K⁺) and a sample solution at 15.0 µg/mL K⁺. Calibration uses a six-point linear fit. System suitability, repeatability, intermediate precision, and spike-recovery tests were performed in accordance with USP General Chapters <621> and <1225>.

Used Instrumentation

• Metrosep C6 - 150/4.0 (L76) ion-exchange column
• 858 Professional Sample Processor with peristaltic pump
• 930 Compact IC Flex Oven/Deg (column oven and degasser)
• Non-suppressed conductivity detector

Main Results and Discussion

The method achieved baseline separation of K⁺ from other cations with a resolution of 4.6 (requirement ≥2.0) and a tailing factor of 1.3 (≤2.0). The calibration curve showed excellent linearity (R=0.99999). Repeatability yielded RSD <0.4% (≤0.5%), and spike-recovery averaged 99.2% (±3% acceptance). Intermediate precision between analysts was within 0.5% (≤2%), demonstrating method robustness.

Benefits and Practical Applications

• High specificity and sensitivity for potassium in complex matrices
• Full compliance with USP monograph criteria
• Rapid analysis via direct injection and non-suppressed conductivity detection
• Simple sample preparation suitable for routine quality control

Future Trends and Prospects

Advancements may include coupling IC with mass spectrometry for trace-level detection, miniaturization for field applications, and adoption of greener eluents. Enhanced automation of sample handling and data processing will further improve throughput and reproducibility.

Conclusion

The validated IC method reliably quantifies potassium in potassium citrate and citric acid oral solutions, fully meeting USP <Potassium Citrate and Citric Acid Oral Solution> monograph specifications and supporting stringent pharmaceutical quality control.

References

1. National Institutes of Health. Potassium Citrate and Citric Acid Oral Solution. DailyMed. Accessed 2024-08-26.
2. Doizi S, Poindexter JR, Pearle MS, et al. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers. J Urol. 2018; DOI:10.1016/j.juro.2018.07.039.
3. U.S. Pharmacopeia. USP-NF Potassium Citrate and Citric Acid Oral Solution Monograph. DOI:10.31003/USPNF_M67530_04_01.
4. U.S. Pharmacopeia/National Formulary. <621> Chromatography. Rockville, MD.
5. U.S. Pharmacopeia/National Formulary. <1225> Validation of Compendial Procedures. Rockville, MD. DOI:10.31003/USPNF_M99945_04_01.